These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
740 related articles for article (PubMed ID: 23999371)
1. [Secondary osteoporosis or secondary contributors to bone loss in fracture. Therapeutic strategy for glucocorticoid-induced osteoporosis]. Hayakawa N; Suzuki A Clin Calcium; 2013 Sep; 23(9):1337-44. PubMed ID: 23999371 [TBL] [Abstract][Full Text] [Related]
2. Glucocorticoid-induced osteoporosis: an update on current pharmacotherapy and future directions. Bultink IE; Baden M; Lems WF Expert Opin Pharmacother; 2013 Feb; 14(2):185-97. PubMed ID: 23317448 [TBL] [Abstract][Full Text] [Related]
3. [Glucocorticoid and Bone. Efficacy and safety of bisphosphonate in treatment of glucocorticoid induced osteoporosis]. Tanaka I Clin Calcium; 2014 Sep; 24(9):1371-8. PubMed ID: 25177010 [TBL] [Abstract][Full Text] [Related]
4. Glucocorticoid-induced osteoporosis: a review on pathophysiology and treatment options. De Nijs RN Minerva Med; 2008 Feb; 99(1):23-43. PubMed ID: 18299694 [TBL] [Abstract][Full Text] [Related]
5. [Assessment of the treatment of glucocorticoid-induced osteoporosis]. Asano S; Suzuki A Clin Calcium; 2013 Mar; 23(3):401-8. PubMed ID: 23445894 [TBL] [Abstract][Full Text] [Related]
6. [Vitamin K2 as a potential therapeutic agent for glucocorticoid-induced osteoporosis]. Tanana I; Oshima H Clin Calcium; 2006 Nov; 16(11):1851-7. PubMed ID: 17079852 [TBL] [Abstract][Full Text] [Related]
8. Prevention and treatment strategies for glucocorticoid-induced osteoporotic fractures. Gourlay M; Franceschini N; Sheyn Y Clin Rheumatol; 2007 Feb; 26(2):144-53. PubMed ID: 16670825 [TBL] [Abstract][Full Text] [Related]
9. [Secondary osteoporosis UPDATE. Clinical significance of glucocorticoid-induced osteoporosis]. Suzuki Y; Sato S Clin Calcium; 2010 May; 20(5):645-53. PubMed ID: 20445275 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of 18 anti-osteoporotic drugs in the treatment of patients with osteoporosis caused by glucocorticoid: A network meta-analysis of randomized controlled trials. Liu Z; Zhang M; Shen Z; Ke J; Zhang D; Yin F PLoS One; 2020; 15(12):e0243851. PubMed ID: 33326444 [TBL] [Abstract][Full Text] [Related]
11. What is new in the treatment of steroid-induced osteoporosis? Liu RH; Werth VP Semin Cutan Med Surg; 2007 Dec; 26(4):203-9. PubMed ID: 18395668 [TBL] [Abstract][Full Text] [Related]
12. Skeletal morbidity in inflammatory bowel disease. van Hogezand RA; Hamdy NA Scand J Gastroenterol Suppl; 2006; (243):59-64. PubMed ID: 16782623 [TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of bisphosphonates for prevention of fracture related to glucocorticoid-induced osteoporosis in Malaysia. Mohd-Tahir NA; Thomas P; Mohamed-Said MS; Makmor-Bakry M; Li SC Int J Rheum Dis; 2018 Mar; 21(3):647-655. PubMed ID: 29105349 [TBL] [Abstract][Full Text] [Related]
14. High fracture risk patients with glucocorticoid-induced osteoporosis should get an anabolic treatment first. Lespessailles E; Chapurlat R Osteoporos Int; 2020 Oct; 31(10):1829-1834. PubMed ID: 32780152 [TBL] [Abstract][Full Text] [Related]
17. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis. Arthritis Rheum; 2001 Jul; 44(7):1496-503. PubMed ID: 11465699 [TBL] [Abstract][Full Text] [Related]